Role of whole body C11-PiB in patients with systemic amyloidosis: a pilot study

Role of whole body C11-PiB in patients with systemic amyloidosis: a pilot study - Whole body C11-PiB in patients with amyloidosis

Status

Recruiting

Phases

Phase 2

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34619

Enrollment

Registered

2010-11-25

Start date

2011-06-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amyloidose (eiwitstapelingen) in diverse organen en weefsels amyloidosis protein deposit

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients known with systemic amyloidosis with known amyloid deposits in various organs

Exclusion criteria

Exclusion criteria: Patients

Design outcomes

Primary

Measure	Time frame
Uptake of 11C-PiB in organs known with amyloid depositions.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results